参考文献/References:
［1］PANAY N, KALU E. Management of premature ovarian failure ［J］. Best Practice & Research Clinical Obstetrics & Gynaecology, 2009, 23 (1): 129-140.
［2］CRAMER D W, XU H, HARLOW B L. Family history as a predictor of early menopause ［J］. Fertility and Sterility, 1995, 64 (4): 740-745.
［3］Torgerson DJ, Thomas RE, Reid DM. Mothers and daughters menopausal ages: is there a link? ［J］. Obstet Gynecol Reprod Biol, 1997，74(1):63-66.
［4］陈静．卵巢早衰的研究进展 ［J］．医学综述，2010，16（18）：2727-2729．
［5］DI PASQUALE E, BECK-PECCOZ P, PERSANI L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene ［J］. American Journal of Human Genetics, 2004, 75 (1): 106-111.
［6］DE BAERE E, DIXON M J, SMALL K W, et al. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype——phenotype correlation ［J］. Human Molecular Genetics, 2001, 10 (15): 1591-1600.
［7］LAML T, PREYER O, UMEK W, et al. Genetic disorders inpremature ovarian failure ［J］. Human Reproduction Update, 2002, 8 (5): 483-491.
［8］COLAFRANCESCO S, PERRICONE C, TOMLJENOVIC L, et al. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants ［J］. American Journal of Reproductive Immunology (New York, N.Y.： 1989), 2013, 70 (4): 309-316.
［9］陈子江，田秦杰，乔杰，等．早发性卵巢功能不全的临床诊疗中国专家共识 ［J］．中华妇产科杂志，2017，52（9）：577-581．
［10］KOLIOS G, MOODLEY Y. Introduction to stem cells and regenerative medicine ［J］. Respiration; International Review of Thoracic Diseases, 2013, 85 (1): 3-10.
［11］GHADAMI M, EL-DEMERDASH E, ZHANG Dong, et al. Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure ［J］. PLOS One, 2012, 7 (3): e 32462.
［12］SHEIKHANSARI G, AGHEBATI-MALEKI L, NOURI M, et al. Current approaches for the treatment of premature ovarian failure with stem cell therapy ［J］. Biomedicine & Pharmacotherapy, 2018,102: 254-262.
［13］孙海翔，丁利军．卵巢衰老的临床干预新进展 ［J］．生殖医学杂志，2018，27（3）：199-203．
［14］孙麟．间充质干细胞用于卵巢早衰治疗的临床前研究进展 ［J］．实用妇科内分泌杂志（电子版），2016，3（19）：16-17．
［15］MOHAMED S A, SHALABY S M, ABDELAZIZ M, et al. Human mesenchymal stem cells partially reverse infertility in Chemotherapy-Induced ovarian failure ［J］. Reproductive Sciences (Thousand Oaks, Calif.), 2018, 25 (1): 51-63.
［16］LEE H J, SELESNIEMI K, NIIKURA Y, et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure ［J］. Journal of Clinical Oncology： Official Journal of the American Society of Clinical Oncology, 2007, 25 (22): 3198-3204.
［17］FU X, HE Y, XIE C, et al. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage ［J］. Cytotherapy, 2008, 10 (4): 353-363.
［18］付霞霏，何援利，王雪峰，等．骨髓间充质干细胞移植修复化疗所致卵巢损伤的实验研究 ［J］．现代妇产科进展，2010，19（6）：410-414．
［19］LIU Jiabin, ZHANG Haiying, ZHANG Yun, et al. Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats ［J］. Molecules and Cells, 2014, 37 (12): 865-872.
［20］BAO Riqiang, XU Ping, WANG Yishu, et al. Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy ［J］. Gynecological Endocrinology： the Official Journal of the International Society of Gynecological Endocrinology, 2018, 34 (4): 320-326.
［21］彭静，肖娜，程腊梅．骨髓来源间充质干细胞对卵巢早衰小鼠的修复作用 ［J］．中南大学学报（医学版），2018，43（1）：7-13．
［22］李欣然,何援利,王雪峰,等.过表达miR-21的骨髓间充质干细胞在化疗性卵巢早衰大鼠模型中的治疗潜能及机制 ［J］.现代妇产科进展,2018,27 (12):924-928，931.
［23］CHEN Xiaoying, WANG Qing, LI Xinran, et al. Heat shock pretreatment of mesenchymal stem cells for inhibiting inhibitingesenchymal stemgranulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure ［J］. Stem Cell Research & Therapy, 2018, 9 (1): 240.
［24］GUPTA S, LODHA P, KARTHICK M S, et al. Role of autologous BoneMarrow-Derived stem cell therapy for follicular recruitment in premature OvarianInsufficiency:review of literature and a case report of world's first baby with ovarian autologous stem cell therapy in a perimenopausal Woman of age 45 year ［J］. Journal of Human Reproductive Sciences, 2018, 11 (2): 125-130.
［25］高小月，张玉泉，杨晓清．人脐带间充质干细胞在组织损伤修复中的研究进展 ［J］．生物医学工程与临床，2018，22（2）：208-213．
［26］李彩霞，王凤英，冷少华，等．脐带基质干细胞移植在卵巢早衰模型小鼠体内的分布 ［J］．第三军医大学学报，2010，32（1）：57-59．
［27］SONG Dan, ZHONG Yun, QIAN Chunfeng, et al. Human umbilical cord mesenchymal stem cells therapy in Cyclophosphamide-Induced premature ovarian failure rat model ［J］. BioMed Research International, 2016: 2517514.
［28］乔联桥，隋晓馨，吴晓梅，等．从子宫内膜间充质干细胞(eMSC)角度看妇科再生医疗 ［J］．转化医学电子杂志，2018，5（8）：19-23．
［29］PATEL A N, PARK E, KUZMAN M, et al. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation ［J］. Cell Transplantation, 2008, 17 (3): 303-311.
［30］LAI D, WANG F, YAO X, et al. Human endometrial mesenchymalstem cells restore ovarian function through improving the renewal of germlinestem cells in a mouse model of premature ovarian failure ［Z］, 2015: 155.
［31］王臻，黄康榕，王月玲，等．经血来源干细胞移植在小鼠卵巢早衰模型中的定位分布 ［J］．西安交通大学学报（医学版），2017，38（6）：803-808．
［32］朱晓帆，孔祥东．人羊水干细胞研究进展 ［J］．中华围产医学杂志，2015，18（12）：946-949．
［33］XIAO Guan-yu, LIU I H, CHENG Chun-chun, et al. Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy［J］. PLOS One, 2014, 9 (9): e106538.
［34］李洁，张建芳，白璐，等．人羊水来源干细胞治疗大鼠卵巢早衰的初步研究 ［J］．现代妇产科进展，2012，21（2）：116-119．
［35］Zhang Q, Xu M, Yao X,et al. Human amniotic epithelial cellsinhibitgranulosa cell apoptosis induced by chemotherapy and restore thefertility ［J］. Stem Cell Res Ther. 2015,6 (1):152.
［36］ZHANG Qiuwan, BU Shixia, SUN Junyan, et al. Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage ［J］. Stem Cell Research & Therapy, 2017, 8 (1): 270.
［37］FU Xiafei, HE Yuanli, WANG Xuefeng, et al. Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis ［J］. Stem Cell Research & Therapy, 2017, 8 (1): 187.
［38］DING Chenyue, ZOU Qinyan, WANG Fuxin, et al. Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor ［J］. Stem Cell Research & Therapy, 2018, 9 (1): 55.
［39］LING Li, FENG Xiushan, WEI Tianqin, et al. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism ［J］. Stem Cell Research & Therapy, 2019, 10 (1): 46.
［40］YU Jun-ying, VODYANIK M A, SMUGA-OTTO K A, et al. Induced pluripotent stem cell lines derived from human somatic cells ［J］. Science, 2007, 318 (5858): 1917-1920.
［41］LIU Te, QIN Wenxing, HUANG Yongyi, et al. Induction of estrogen-sensitive epithelial cells derived from humaninduced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure ［J］. DNA and Cell Biology, 2013, 32(12): 685-698.
［42］Liu T, Li Q, Wang S,et al. Transplantation of ovariangranulosalike cellsderived from human induced pluripotent stem cells for thetreatment of murine premature ovarian failure ［J］. Molecular Medicine Reports, 2016,13 (6):5053-5058.
［43］WEN Yanfei, HE Wen, JIANG Manbo, et al. Deriving cells expressing markers of female germ cells from premature ovarian failure patient-specific induced pluripotent stem cells ［J］. Regenerative Medicine, 2017, 12 (2): 143-152.
［44］HANNA C B, HENNEBOLD J D. Ovarian germline stem cells: an unlimited source of oocytes? ［J］. Fertility and Sterility, 2014, 101 (1): 20-30.
［45］ZOU Kang, YUAN Zhe, YANG Zhaojuan, et al. Production of offspring from a germline stem cell line derived from neonatal ovaries ［J］. Nature Cell Biology, 2009, 11 (5): 631-636.
［46］KIZUKA-SHIBUYA F, TOKUDA N, TAKAGI K, et al. Locally existing endothelial cells andpericytes in ovarian stroma,but not bone marrow-derived vascular progenitorcells,play a central role in neovascularization during follicular development inmice［Z］, 2014: 10.
［47］DING X, LIU G, XU B, et al. Human GVoocytes generated by mitotically active germ cells obtained from follicularaspirates ［Z］, 2016: 28218.
［48］STIMPFEL M, CERKOVNIK P, NOVAKOVIC S, et al. Putative mesenchymal stem cells isolated from adult human ovaries ［J］. Journal of Assisted Reproduction and Genetics, 2014, 31 (8): 959-974.
［49］BESIKCIOGLU H E, SARIBAS G S, OZOGUL C, et al. Determination of the effects of bone marrow derived mesenchymal stem cells and ovarian stromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats ［J］. Taiwanese Journal of Obstetrics & Gynecology, 2019, 58 (1): 53-59.
相似文献/References:
[1]刘红,樊英,张国楠,等.子宫内膜浆液性腺癌的临床研究进展[J].中国计划生育和妇产科,2010,(03):0.
[2]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[3]刘彩艳.宫角妊娠34例诊治分析[J].中国计划生育和妇产科,2010,(04):0.
[4]何博.妊娠合并先天性心脏病的诊治研究进展[J].中国计划生育和妇产科,2010,(04):0.
[5]卢庆.妊娠期急性脂肪肝研究进展[J].中国计划生育和妇产科,2010,(05):0.
[6]张兰,张波,邱艳,等.甲氨蝶呤联合米非司酮治疗未破裂型输卵管妊娠的价值[J].中国计划生育和妇产科,2010,(06):0.
ZHANG Lan,ZHANG Bo,QIU Yan..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[7]严琴,祝茹.保守治疗完全性胎盘植入成功1例[J].中国计划生育和妇产科,2011,(01):0.
[8]万璟,杨越波,李小毛,等.剖宫产术后子宫瘢痕妊娠的诊治分析[J].中国计划生育和妇产科,2011,(03):0.
WAN Jing,YANG Yue-bo,LI Xiao-mao.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[9]卢建军,苏日娜.子宫剖宫产瘢痕妊娠治疗分析10例[J].中国计划生育和妇产科,2011,(05):0.
LU Jian-jun,SU Ri-na.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[10]张冬雅,史惠蓉.宫角妊娠误诊为绒毛膜癌12例临床分析[J].中国计划生育和妇产科,2011,(05):0.
ZHANG Dong-ya,SHI Hui-rong.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.